New reports examine psychiatric risks of varenicline for smoking cessation

JAMA. 2012 Jan 11;307(2):129-30. doi: 10.1001/jama.2011.1924.
No abstract available

Publication types

  • News

MeSH terms

  • Benzazepines / adverse effects*
  • Drug Labeling
  • Hospitalization / statistics & numerical data
  • Humans
  • Nicotinic Agonists / adverse effects*
  • Quinoxalines / adverse effects*
  • Reproducibility of Results
  • Risk
  • Smoking Cessation / methods*
  • Suicidal Ideation
  • Suicide / statistics & numerical data*
  • Suicide, Attempted / statistics & numerical data*
  • United States / epidemiology
  • United States Food and Drug Administration
  • Varenicline

Substances

  • Benzazepines
  • Nicotinic Agonists
  • Quinoxalines
  • Varenicline